Fmr LLC Boosts Position in SPDR S&P Biotech ETF (XBI)

Fmr LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 39,992 shares of the exchange traded fund’s stock after buying an additional 8,273 shares during the quarter. Fmr LLC owned about 0.07% of SPDR S&P Biotech ETF worth $3,807,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of XBI. Rockefeller Capital Management L.P. purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $130,000. WP Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $133,000. Trust Co. of Vermont purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $136,000. Squar Milner Financial Services LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $139,000. Finally, Cypress Capital Management LLC WY raised its stake in shares of SPDR S&P Biotech ETF by 51.8% in the second quarter. Cypress Capital Management LLC WY now owns 2,065 shares of the exchange traded fund’s stock worth $197,000 after purchasing an additional 705 shares during the last quarter.

Shares of SPDR S&P Biotech ETF stock opened at $86.10 on Friday. SPDR S&P Biotech ETF has a 52 week low of $78.46 and a 52 week high of $101.55.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 26th. Stockholders of record on Monday, September 24th were issued a $0.0726 dividend. The ex-dividend date was Friday, September 21st. This is a positive change from SPDR S&P Biotech ETF’s previous quarterly dividend of $0.06. This represents a $0.29 annualized dividend and a dividend yield of 0.34%.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: Why is the conference call important?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply